Vendor Risk Management and HIPAA Compliance for Real-World Evidence Data Companies

Kevin Henry

HIPAA

Published Updated

12 minutes read
Share this article
Vendor Risk Management and HIPAA Compliance for Real-World Evidence Data Companies

Real-world evidence (RWE) companies may collect, link, analyze, host, or disclose health data for different organizations and purposes. Whether HIPAA applies—and whether a vendor is a business associate—depends on the parties’ roles, the data involved, and the services being performed, not simply on the fact that a project uses health information.

A sound vendor risk program connects those legal roles to practical controls: assess data flows before onboarding, define permitted uses in contracts, verify safeguards and subcontractors, and prepare for incidents. HIPAA sets specific requirements for covered entities and business associates; the additional diligence practices below help organizations manage vendor risk but should not be mistaken for separate universal HIPAA mandates.

Which HIPAA requirements apply to RWE data vendors?

The HIPAA Rules apply to covered entities—health plans, health care clearinghouses, and certain health care providers—and their business associates. A data or analytics company may be a business associate when it performs a regulated function or provides a covered service on behalf of a covered entity involving protected health information (PHI). Examples can include data analysis, claims processing, and data aggregation. A vendor that does not meet the definition of a covered entity or business associate is not subject to the HIPAA Rules merely because it handles health-related information. See HHS guidance on covered entities and business associates and HHS’s business associate guidance.

For RWE work, determine whether a company is acting on behalf of a covered entity or another business associate, and whether its work involves PHI. A vendor’s role can differ from project to project. For example, an organization contracted to analyze PHI for a covered entity’s health care operations may be a business associate, while an independent researcher receiving information for research is not automatically a business associate. HHS explains that research disclosures permitted by the Privacy Rule do not, by themselves, require a business associate agreement; the disclosure must still have a valid HIPAA basis. See HHS’s guidance on research disclosures and business associate contracts.

If the company is a business associate, the HIPAA Privacy Rule governs its permitted uses and disclosures of PHI, while the HIPAA Security Rule requires administrative, physical, and technical safeguards for electronic PHI (ePHI). Business associates are also directly liable for certain HIPAA requirements. HHS summarizes the HIPAA Security Rule and HIPAA Privacy Rule.

Research teams should distinguish PHI from data that has been properly de-identified under 45 CFR 164.514. HIPAA recognizes two de-identification methods: Expert Determination and Safe Harbor. A limited data set is different: it excludes certain direct identifiers but remains PHI and is subject to a data use agreement when disclosed for permitted purposes. See HHS’s de-identification guidance and HHS’s HIPAA and research guidance.

How should RWE companies assess vendor risk before onboarding?

Start by mapping the data and services, not by relying on a vendor’s marketing label. Record what information the vendor will receive or generate, whether it can identify individuals, where it will be stored or accessed, who will use it, and whether it will be shared with other vendors. Identify the project purpose and determine whether the vendor acts on behalf of a covered entity or business associate.

For vendors handling PHI, assess risk in proportion to the sensitivity of the data, the vendor’s access, and the potential impact of a compromise. Review the vendor’s written security and privacy policies, access management, workforce training, incident procedures, backup and recovery arrangements, and process for managing subcontractors. For ePHI, a covered entity or business associate must conduct an accurate and thorough Security Risk Analysis; HHS guidance says this analysis should identify where ePHI is created, received, maintained, or transmitted, along with relevant threats and vulnerabilities. See HHS guidance on Security Risk Analysis.

Ask for evidence that supports the vendor’s answers, such as relevant policy excerpts, assessment summaries, incident-response procedures, and access-control descriptions. A vendor’s self-attestation or third-party report can inform diligence, but neither should be treated as a substitute for determining whether the arrangement meets your organization’s needs and applicable obligations. HIPAA does not establish a universal vendor questionnaire, audit format, or review schedule for every organization.

Document the decision, identified risks, required safeguards, responsible owners, and any conditions that must be met before data access begins. If the vendor’s role or data access changes later—for example, a new dataset, use, system, or subcontractor—reassess whether the original risk decision and contract remain appropriate.

What should a HIPAA business associate agreement cover?

A business associate agreement (BAA) is a required contract or written arrangement when a covered entity engages a business associate to handle PHI, and similar requirements apply between a business associate and its business associate subcontractor. A BAA should describe the permitted and required uses and disclosures of PHI, prohibit other uses or disclosures except as permitted by the agreement or required by law, and require appropriate safeguards. HHS lists required provisions in its business associate contract guidance.

For an RWE engagement, make the permitted scope specific. Identify the services, data elements, project purposes, approved recipients, and any allowed data linkage, aggregation, or analysis. Avoid language that could be read to authorize broad secondary use or disclosure beyond the parties’ intended arrangement. The BAA should also address any Privacy Rule duties the vendor performs for the covered entity, such as supporting individual access, amendments, or disclosure-accounting obligations when applicable.

The agreement must require the business associate to report impermissible uses or disclosures and breaches of unsecured PHI, provide for appropriate safeguards for ePHI, and require subcontractors with access to PHI to accept applicable restrictions and conditions. It should address access to relevant practices and records by HHS for compliance purposes, return or destruction of PHI at termination when feasible, and termination rights for material violations. HHS’s sample BAA provisions describe these elements; they are not a project-specific substitute for legal review.

Operational terms can make the agreement more useful: name incident contacts, set a contractual reporting deadline that allows the covered entity to meet its obligations, specify the information needed to investigate an event, and describe cooperation with containment and remediation. HIPAA sets a maximum notification period for a business associate after discovery of a breach of unsecured PHI; the parties can agree to a shorter contractual deadline.

Ready to assess your HIPAA security risks?

Join thousands of organizations that use Accountable to identify and fix their security gaps.

Take the Free Risk Assessment

How can organizations verify vendor safeguards and subcontractors?

Ask the vendor to describe the safeguards relevant to the actual service and data flow. Depending on the arrangement, that may include role-based access, authentication, audit logging, secure data transfer, protection of stored ePHI, workforce training, physical safeguards, vulnerability management, backup and recovery, and secure disposal. The Security Rule requires reasonable and appropriate safeguards, taking account of factors such as the organization’s size, capabilities, infrastructure, costs, and the probability and criticality of risks. See HHS’s Security Rule summary.

Match evidence to the claim being assessed. For example, a written policy shows what the vendor says it does; a sample access review or incident exercise may help show how a process operates. If the vendor supplies an independent assessment or certification, check its scope, date, systems covered, exceptions, and whether the service in your contract is included. Do not treat a certificate or report as proof that the organization is universally “HIPAA certified” or that every HIPAA obligation is satisfied.

Obtain a clear inventory of subcontractors that may create, receive, maintain, or transmit PHI for the service. Under the HIPAA Rules, a business associate must obtain appropriate assurances from such subcontractors and ensure they agree to applicable safeguards and restrictions. See 45 CFR 164.314(a) and HHS’s BAA provisions. As a practical contract control, specify how the vendor will notify you of material subcontractor changes and how you can assess risks before affected data is routed to a new provider.

Keep evidence of diligence and remediation in a reviewable record: the assessment, supporting documents, decisions, contract terms, identified gaps, and follow-up actions. This documentation supports governance and can help show how risks were considered; it does not replace the organization’s own Security Risk Analysis where that analysis is required.

How should RWE data access, use, and disclosure be controlled?

Use the BAA and related project documents to translate the approved purpose into operational boundaries. Define which users and systems may access each dataset, which fields are necessary, what outputs can be released, and whether linkage or onward disclosure is permitted. Assign access according to job responsibilities, remove access when it is no longer needed, and retain records that let the organization review access and investigate unusual activity.

Apply the minimum-necessary standard where it applies to the use, disclosure, or request for PHI. HHS notes that business associates generally must limit their uses and disclosures to what is permitted by the BAA and may not use or further disclose PHI in a way that would violate the Privacy Rule if done by the covered entity. See HHS guidance on business associate uses and disclosures.

Keep the data’s status clear throughout the workflow. If a dataset is intended to be de-identified, document which method under 45 CFR 164.514 was used and retain the supporting analysis or determination. Under Expert Determination, a qualified expert must determine that the risk of identification is very small and document the methods and results. Under Safe Harbor, specified identifiers must be removed, and the covered entity must not have actual knowledge that remaining information could identify an individual. See HHS’s guidance on de-identification.

Do not assume that removing names alone de-identifies a dataset. Rare events, detailed dates, geography, and combinations of attributes may create identification risk. If the information remains PHI, apply the relevant Privacy Rule permissions and safeguards. If it qualifies as de-identified under HIPAA, assess other applicable laws, contractual restrictions, and commitments that may still govern its use.

What evidence supports ongoing vendor monitoring and incident response?

Maintain current records of vendor contacts, approved services, data flows, subcontractors, BAAs, risk decisions, safeguard evidence, and agreed remediation. Revisit the risk assessment when material changes occur, such as a new purpose, new data, a different hosting arrangement, a subcontractor change, or a security incident. HIPAA requires covered entities and business associates to review and modify security measures as needed to continue providing reasonable and appropriate protection of ePHI. See HHS’s Security Rule summary.

For incident readiness, agree in advance on how the vendor will report suspected and confirmed events, preserve evidence, provide relevant timelines and affected-data details, support containment, and cooperate with investigation and remediation. A business associate must notify the covered entity after discovering a breach of unsecured PHI without unreasonable delay and no later than 60 calendar days after discovery. The covered entity remains responsible for required notifications to affected individuals and HHS, subject to the applicable rules. See HHS’s Breach Notification Rule guidance.

When an event occurs, coordinate promptly with the vendor and the covered entity’s privacy, security, legal, and operational leads. Preserve relevant logs and communications, determine what information was involved and who may have accessed it, contain ongoing exposure, and document decisions. Do not wait until the outside notification deadline to begin assessment: notification timing, responsibility, and required details depend on the facts and the parties’ roles.

In summary, effective RWE vendor risk management starts with correctly identifying each party’s HIPAA role, then connects that determination to a precise BAA, evidence-based safeguard review, controlled data use, and a tested incident process. Treat de-identification as a documented standard—not a label—and keep vendor oversight aligned with actual data flows and project changes.

FAQs

When is an RWE data vendor a HIPAA business associate?

An RWE vendor is generally a business associate when it performs a regulated function or provides a covered service on behalf of a HIPAA covered entity, involving PHI, or when it acts as a subcontractor handling PHI on behalf of a business associate. A vendor’s role depends on what it does, for whom, and what information it handles. A researcher receiving PHI for research is not automatically a business associate; the covered entity must still have a permissible basis for the disclosure. See HHS business associate guidance and HHS research guidance.

What must a business associate agreement include?

A BAA must establish permitted and required PHI uses and disclosures, require appropriate safeguards, restrict unauthorized use or disclosure, address reporting of impermissible uses and breaches, flow applicable requirements down to subcontractors, and include other required provisions such as cooperation with individual-rights obligations when applicable, access to relevant records for HHS, and return or destruction of PHI at termination when feasible. See HHS’s business associate contract guidance.

Does de-identified health data remain subject to HIPAA?

Health information that meets HIPAA’s de-identification standard under 45 CFR 164.514 is no longer PHI under the Privacy Rule. The regulation provides two methods: Expert Determination and Safe Harbor. If the data does not meet either method, or if it is only a limited data set, it may remain PHI and require applicable HIPAA protections and permissions. See HHS’s de-identification guidance.

How should an RWE company respond to a vendor data breach?

Promptly activate the incident process: notify the appropriate covered entity or business associate contacts, contain the incident, preserve evidence, determine what PHI may have been affected, and support the investigation and mitigation. A business associate must notify the covered entity of a breach of unsecured PHI without unreasonable delay and no later than 60 days after discovery; the BAA may require faster notice. The covered entity must assess and provide any notifications required by the Breach Notification Rule. See HHS breach notification guidance.

Share this article

Ready to assess your HIPAA security risks?

Join thousands of organizations that use Accountable to identify and fix their security gaps.

Take the Free Risk Assessment

Related Articles